Clinical Trial Update: Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/Ritonavir [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of pitavastatin on lipid profiles in HIV-infected patients with dyslipidemia receiving boosted atazanavir/ritonavir; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• HIV Infection

Drugs mentioned

• ATAZANAVIR (atazanavir)
• Pitavastatin (Pitavastatin)
• Ritonavir (Ritonavir)

Snippet

Sponsor: Ramathibodi Hospital | Conditions: HIV, Dyslipidemia | Phase 4 | Status: COMPLETED | Results posted: 2016-10-10